Patent application number | Description | Published |
20120128789 | USE OF XENON FOR TREATING HYPERSENSITIVITY TO PAIN - The invention relates to a gaseous mixture containing oxygen (O2) and a volume proportion of 20 to 70% of xenon (Xe) for use as an inhalable drug for preventing or treating hypersensitivity to pain in humans or animals, in particular hypersensitivity to pain expressed as hyperalgesia or allodynia. | 05-24-2012 |
20120213860 | XENON-BASED INHALABLE DRUG FOR TREATING OR PREVENTING INDUCED DYSKINESIA - The invention relates to the use of a gaseous drug based on gaseous xenon for inhalation for treating or preventing in mammals dyskinesia induced by a dopaminergic agonist. The invention is particularly useful for treating levodopa induced dyskinesia in patients being treated for Parkinson's disease. | 08-23-2012 |
20130071487 | XENON-BASED INHALABLE DRUG FOR PREVENTING ADDICTION RELAPSES IN HUMANS - The invention relates to a gas composition containing xenon gas for use in preventing the relapse of a patient who has been weaned from at least one psychotropic product which resulted in said patient becoming habituated, the xenon being administered to the patient by inhalation. The composition of the invention contains an effective volume proportion of xenon, in particular from 5 to 70% by volume of xenon. DRAWING: FIG. | 03-21-2013 |
20130095194 | USE OF INHALED NITROUS OXIDE OR XENON FOR PREVENTING NEUROPATHIC PAIN CAUSED BY CANCER CHEMOTHERAPY - The invention relates to a gaseous inhalable medicament containing xenon or N | 04-18-2013 |